¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16
±³À°ÀÏÀÚ : 2022-07-16
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ¶óº¥´õ·ë  
±³À°ÁÖÁ¦ : ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò 
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼­¿ïÁöºÎȸ  
´ã´çÀÚ : Á¤ÇýÁ¤ ±³¼ö
¿¬¶ôó : 02-2260-7315  
À̸ÞÀÏ : humeong01@nmc.or.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ ȸ¿ø ÀÌ¿Ü´Â 50¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:05~14:25 Dupilumab vs JAK Inhibitor for atopic dermatitis  ¾ÈÁö¿µ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:25~14:45 Safer use of JAK inhibitor  ±è¿ë±æ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:45~15:05 Practical treatment approaches of chronic urticaria in Korea  À̵¿ÈÆ(¼­¿ïÀÇ´ë) 
Åä·Ð 07-16 ¶óº¥´õ·ë 15:05~15:15 Q&A  () 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:15~15:35 Treatment of nail dystrophy and ingrowing nail  ¿Àº´È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:35~15:55 Finasteride vs dutasteride for androgenetic alopecia  ÃÖÁö¿õ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:55~16:15 Supportive and adjunctive treatment for hair loss  ÃÖÀ±Áø(¿¬¼¼º½ºûÇǺΰú) 
Åä·Ð 07-16 ¶óº¥´õ·ë 16:15~16:25 Q&A  () 
È޽Ġ07-16 ¶óº¥´õ·ë 16:25~16:50   () 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 16:50~17:10 Increasing the usefulness of patch test in allergic contact dermatitis  °íÁÖ¿¬(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 17:10~17:30 My experience of hypopigmenting agents including tranexamic acid in clinical practice  À¯È­Á¤(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 17:30~17:50 RF vs HIFU: basic steps for skin rejuvenation  Á¤¿î°æ(À¯¾ØÁ¤ÇǺΰú) 
Åä·Ð 07-16 ¶óº¥´õ·ë 17:50~18:00 Q&A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³âµµ ºÎ»ê±¤¿ª½ÃÀÇ»çȸ Á¦4±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤ : 2022-07-17
´ÙÀ½±Û ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ⸳ 10Áֳ⠱â³ä ½ÉÆ÷Áö¾ö : 2022-07-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
825 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø ¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2018 : 2018-10-14 0 867 2018-09-06
824 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-13 0 955 2018-09-06
823 ¼­¿ï °Ç±¹´ëÇб³º´¿ø Á¦9ȸ ±¤Áø,µ¿´ë¹®,¼ºµ¿,Á߶û,Áß±¸ÀÇ»çȸ Çмú´ëȸ : 2018-10-13 0 972 2018-09-06
822 ´ëÀü 2018³â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-13 0 956 2018-09-06
821 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø 2018 ±Ý¿¬¿¬±¸È¸ Á¦4Â÷ ½ÉÆ÷Áö¾ö : 2018-10-13 0 724 2018-09-06
820 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø 2018³â ³»°ú ¿¬¼ö°­Á : 2018-10-13 0 934 2018-09-06
819 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦18ȸ »ï¼ºÈ²¹Ý½ÉÆ÷Áö¿ò : 2018-10-13 0 890 2018-09-06
818 °­¿ø 2018³â ´ëÇÑÃé´ãµµÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-13 0 498 2018-09-06
817 ¼­¿ï ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-10-13 0 628 2018-09-06
816 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø The 6th GSTEC (Gangnam Severance Single Topic Endoscopic Conference) : 2018-10-13 0 579 2018-09-06
815 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-12 0 765 2018-09-06
814 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-12 0 2,684 2018-09-06
813 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-11 0 639 2018-09-06
812 ¼­¿ï ´ëÇÑÁø´Ü¸é¿ªÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2018-10-11 0 492 2018-09-06
811 ºÎ»ê ´ëÇѺñ´¢±â°úÇÐȸ °ú¹Î¼º¹æ±¤ ¾à¹°Ä¡·áÀÇ Çã ¿Í ½Ç : 2018-10-11 0 1,024 2018-09-06
1351 | 1352 | 1353 | 1354 | 1355 | 1356 | 1357 | 1358 | 1359 | 1360
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷